Breast cancer molecular subtypes and oxidative DNA damage

Applied Immunohistochemistry and Molecular Morphology

Volumn 23, Issue 10, 2015, Pages 696-703

  Jakovcevic, Danica ^a   Dedic Plavetic, Natalija ^b   Vrbanec, Damir ^b   Jakovcevic, Antonia ^c   Jakic Razumovic, Jasminka ^c  

^a University Hospital Sveti Duh   (Croatia)

^b Department of Medical Oncology ^*  (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

8 OHdG; Breast cancer molecular subtypes; oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; TUMOR MARKER; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; DNA;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SIZE; DNA DAMAGE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; AGED; ANALOGS AND DERIVATIVES; BREAST TUMOR; CLASSIFICATION; FEMALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEOXYGUANOSINE; DNA DAMAGE; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; OXIDATION-REDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84947292873     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0000000000000135     Document Type: Article

References (46)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127: 2893-2917.
2. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.
3. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869-10874.
4. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415:530-536.
5. Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101:736-750.
6. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367-5374.
7. Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17: 1195-1214.
8. Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106(suppl 1): 289-295.
9. Richter C, Suter M, Walter PB. Mitochondrial free radical damage and DNA repair. Biofactors. 1998;7:207-208.
10. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep. 1997;17:3-8.
11. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313:17-29.
12. Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 1988;195:255-271.
13. Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989;246:491-494.
14. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21:361-370.
15. Poulsen HE, Prieme H, Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev. 1998;7:9-16.
16. Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 1990;11:1447-1450.
17. Cheng KC, Cahill DS, Kasai H, et al. 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem. 1992;267:166-172.
18. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997;387:147-163.
19. Hirano T. Repair system of 7, 8-dihydro-8-oxoguanine as a defense line against carcinogenesis. J Radiat Res. 2008;49:329-340.
20. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007;115:81-103.
21. Toyokuni S, Okamoto K, Yodoi J, et al. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1-3.
22. Matsui A, Ikeda T, Enomoto K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 2000;151:87-95.
23. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetio-logical relevance of 8-hydroxyguanosine in human breast carcino-genesis. Eur J Cancer. 1996;32A:1209-1214.
24. Karihtala P, Kauppila S, Puistola U, et al. Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopatho-logy. 2011;58:854-862.
25. Sova H, Jukkola-Vuorinen A, Puistola U, et al. 8-hydroxydeoxy-guanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer. 2010;102:1018-1023.
26. Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736-1747.
27. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumours of the Breast. Lyon: IARC; 2012.
28. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19:403-410.
29. Hammond ME, Hayes DF, Wolff AC, et al. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6: 195-197.
30. Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american patholo-gists clinical practice guideline update. J Clin Oncol. 2013;31: 3997-4013.
31. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
32. Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol. 2002;117:723-728.
33. Katayama S, Nakayama T, Ito M, et al. Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol Histopathol. 2005;20:119-126.
34. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5:5-23.
35. Harbeck N, Thomssen C. A new look at node-negative breast cancer. Oncologist. 2011;16(suppl 1):51-60.
36. Felty Q, Xiong WC, Sun D, et al. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry. 2005;44:6900-6909.
37. Okoh V, Deoraj A, Roy D. Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta. 2011;1815:115-133.
38. Mobley JA, Brueggemeier RW. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis. 2004;25:3-9.
39. Loft S, Olsen A, Moller P, et al. Association between 8-oxo-7, 8-dihydro-2-deoxyguanosine excretion and risk of postmenopausal breast cancer: nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013;22:1289-1296.
40. Karihtala P, Kauppila S, Soini Y, et al. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer. 2011;11: 262-267.
41. Karihtala P, Kauppila S, Puistola U, et al. Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype. Br J Cancer. 2012;106: 344-347.
42. Xie H, Xia K, Rong H, et al. Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast. 2013;22:707-712.
43. Shen J, Deininger P, Hunt JD, et al. 8-hydroxy-2-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574-580.
44. Sheridan J, Wang LM, Tosetto M, et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer. 2009; 100:381-388.
45. Karihtala P, Soini Y, Vaskivuo L, et al. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer. 2009;19: 1047-1051.
46. Kuo HW, Chou SY, Hu TW, et al. Urinary 8-hydroxy-2-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients. Mutat Res. 2007;631:62-68.